Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × tislelizumab × Clear all

NCT05978102 2025-07-23

A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05840835 2023-08-08

IMMINENT-01

Phase 1/2 Unknown

Other solid neoplasm

Advanced Solid Tumor